| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/01/2013 | CN103070903A Drug composition for curing pyogenic infection ulcer and preparing method thereof |
| 05/01/2013 | CN103070902A Drug for curing epidemic meningitis |
| 05/01/2013 | CN103070899A Method for separating and purifying total flavone of dandelion |
| 05/01/2013 | CN103070892A Application of freeze-dried purslane in preparing drug for treating herpes zoster |
| 05/01/2013 | CN103070891A Capsule containing Hypericum perforatum extract |
| 05/01/2013 | CN103070890A Preparation method for microecological preparation used for preventing and treating reproductive tract infection of dairy cow |
| 05/01/2013 | CN103070881A Vagina bacteriostatic virus-killing composition and application thereof |
| 05/01/2013 | CN103070876A Anti-Japanese-encephalitis-virus-infection compositions and applications thereof |
| 05/01/2013 | CN103070870A Application of carbenoxolone in preparing anti-dengue virus medicine |
| 05/01/2013 | CN103070862A Application of Harmine derivative to preparation of antibacterial medicine |
| 05/01/2013 | CN103070858A Application of benzo Alpha-pyrone compound as Gamma-type human herpes virus-resistant medicine |
| 05/01/2013 | CN103070856A Composition containing andrographolidi natrii bisulfis and preparation method and application thereof |
| 05/01/2013 | CN103070843A Oral preparation containing andrographolide and preparation method thereof |
| 05/01/2013 | CN103070839A Sitafloxacin tablet and preparation method thereof |
| 05/01/2013 | CN103070830A Production method for 20-percent tilmicosin granules |
| 05/01/2013 | CN103070827A Method for preparing tulathromycin soluble powder |
| 05/01/2013 | CN103070821A Method for preparing tulathromycin oral solution |
| 05/01/2013 | CN103070819A Method for preparing tulathromycin oral paste |
| 05/01/2013 | CN103070813A Toothpaste applicable to chronic sinusitis patients |
| 05/01/2013 | CN103070811A Tea tree oil antibacterial microcapsule and preparation method and application thereof |
| 05/01/2013 | CN103070809A Chinese medicinal anti-bacteria moistening curing foot-massage solution and preparation method |
| 05/01/2013 | CN103070806A Chinese medicinal anti-bacteria cleaning care solution and preparation method thereof |
| 05/01/2013 | CN103070804A Acne removing cleanser |
| 05/01/2013 | CN103070629A Care sanitary wet tissue |
| 05/01/2013 | CN103070332A Anti-cariogenic bacteria saccharide composition |
| 05/01/2013 | CN102643255B Andrographolide compound |
| 05/01/2013 | CN102579302B Liquid soap for pre-operation sterilization |
| 05/01/2013 | CN102526054B Compound enrofloxacin pellets and preparation method thereof |
| 05/01/2013 | CN102525938B Minocycline hydrochloride nano calcium carbonate preparation and preparation method thereof |
| 05/01/2013 | CN102512544B Traditional Chinese medicinal preparation for treating athlete's foot (barbier) and vaginitis and preparation method of same |
| 05/01/2013 | CN102488864B Medicinal composition for treating herpes zoster |
| 05/01/2013 | CN102430071B Medicament for treating herpes zoster |
| 05/01/2013 | CN102429862B Sustained-release povidone iodine eye drops |
| 05/01/2013 | CN102415991B Enrofloxacin long-acting injection and preparation method thereof |
| 05/01/2013 | CN102363621B Cefminox sodium hexahydrate, preparation method thereof and pharmaceutical composition containing hexahydrate |
| 05/01/2013 | CN102363043B Swine C-type foot-and-mouth disease genetic engineering vaccine adjuvant, and preparation method thereof |
| 05/01/2013 | CN102363040B Antimicrobial peptide preparation for mucosal tissues |
| 05/01/2013 | CN102363015B Compound detoxifying pill |
| 05/01/2013 | CN102357116B Healthcare product for mammitis of milch goats |
| 05/01/2013 | CN102349934B Extraction process of effective ingredients from cordyceps mycelia |
| 05/01/2013 | CN102337263B siRNA (Small interfering ribonucleic acid) capable of inhibiting expression of enterovirus 71 type gene, composition and application |
| 05/01/2013 | CN102335389B Kidney-tonifying spleen-nourishing traditional Chinese medicine formula for treating chronic hepatitis B and chronic hepatitis B virus carriers |
| 05/01/2013 | CN102327606B Brucella live vaccine and production method thereof |
| 05/01/2013 | CN102327591B Phlegm-eliminating pill |
| 05/01/2013 | CN102319210B Veterinary long-acting cefquinome sulfate injection and preparation method thereof |
| 05/01/2013 | CN102302553B Extraction method of key components of Chinese magnoliavine fruit medicament |
| 05/01/2013 | CN102293951B Traditional Chinese medicine for treating toxic heat type influenza and preparation method thereof |
| 05/01/2013 | CN102293735B Antifungal imidazole medicament controlled-release gel and preparation method thereof |
| 05/01/2013 | CN102286106B Sandwich outer membrane protein display vector and escherichia coli vaccine prepared by applying same |
| 05/01/2013 | CN102274208B Novel application of caffeoylquinic acid compound |
| 05/01/2013 | CN102218060B Amoxicillin and probenecid compound suspension injection for livestock and preparation method thereof |
| 05/01/2013 | CN102205000B Callicarpa nudiflora Hook. et Arn. extract, preparation method and application thereof |
| 05/01/2013 | CN102199196B Gene engineering antibacterial peptide and preparation method and application thereof |
| 05/01/2013 | CN102190718B Recombined litopenaeus setiferus protein SF-P9, preparation method and application thereof |
| 05/01/2013 | CN102166285B Umbilical plaster for treating allergic skin itching and psoriasis and preparation method thereof |
| 05/01/2013 | CN102133315B Chinese medicinal compound preparation for resisting human papilloma virus |
| 05/01/2013 | CN102018953B Pharmaceutical composition containing nocathiacin antibiotics |
| 05/01/2013 | CN101979566B Sulpho-oligodeoxynucleotide with immunostimulation activities and application thereof |
| 05/01/2013 | CN101948516B Establishment and application of vaccinia virus vector-based reverse genetics system |
| 05/01/2013 | CN101897965B Hepatitis B virus dendritic cell therapeutic vaccine and preparation method thereof |
| 05/01/2013 | CN101760457B SiRNA inhibiting duplication of A type influenza virus and coding sequence thereof |
| 05/01/2013 | CN101607995B Monoclonal antibody or binding activity fragment thereof of H5 subtype avian influenza virus hemagglutinin protein and application thereof |
| 05/01/2013 | CN101603042B RNA interference target for treating hepatitis B virus infection |
| 05/01/2013 | CN101495469B N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives as antagonist of TRPV1 or VR1 receptor, preparation thereof and therapeutic use thereof |
| 05/01/2013 | CN101167822B Tibetan medicine bongga extraction and its application in preparing antiviral medicine |
| 04/30/2013 | USRE44186 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 04/30/2013 | US8431688 Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis |
| 04/30/2013 | US8431617 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431568 Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors |
| 04/30/2013 | US8431530 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 04/30/2013 | US8431528 Antibacterial Lactobacillus GG peptides and methods of use |
| 04/30/2013 | US8431354 Bacterial pheromones and uses therefor |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/30/2013 | CA2673249C 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 04/30/2013 | CA2672250C Antiviral indoles |
| 04/30/2013 | CA2620175C Disinfectant with quaternary ammonium polymers and copolymers |
| 04/30/2013 | CA2579199C Substituted isoxazoles as fungicides |
| 04/30/2013 | CA2578877C Pharmaceutical use of graptopetalum and related plants |
| 04/30/2013 | CA2452491C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 04/30/2013 | CA2431483C Antiviral agents |
| 04/30/2013 | CA2417495C Methods for treating cell proliferative disorders and viral infections |
| 04/30/2013 | CA2403964C Compositions and methods for dendritic cell-based immunotherapy |
| 04/30/2013 | CA2399321C Adenovirus formulations |
| 04/27/2013 | CA2794397A1 Modulation of ul24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection |
| 04/25/2013 | WO2013059638A1 Combination treatment (eg. with abt-072 or abt -333) of daas for use in treating hcv |
| 04/25/2013 | WO2013059630A1 Methods for treating hcv comprising at least two direct acting antiviral agent, ribavirin but not interferon. |
| 04/25/2013 | WO2013059299A1 Antibodies for interferon subtypes and interferon/interferon receptor ternary complex and uses thereof |
| 04/25/2013 | WO2013059265A1 A compound for the treatment of hepatitis c |
| 04/25/2013 | WO2013058681A2 Substituted phenoxyacetic acids and esters and amides thereof, comprising a 2,6-dioxo-2,3,6,7-tetrahydro-1н-purine-8-yl fragment and constituting а2a adenosine receptor antagonists, and the use thereof |
| 04/25/2013 | WO2013058484A2 Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same |
| 04/25/2013 | WO2013058441A1 Non-genetic antibiotic resistant inhibitor |
| 04/25/2013 | WO2013057715A1 Adjuvanted influenza b virus vaccines for pediatric priming |
| 04/25/2013 | WO2013057619A1 Novel phenicol antibacterials |
| 04/25/2013 | WO2013057593A1 Process for the preparation of lersivirine |
| 04/25/2013 | WO2013057422A1 Anti-diabetic aminosteroid derivatives |
| 04/25/2013 | WO2013057322A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | WO2013057253A1 Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | WO2013057251A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | WO2013057222A2 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |